Manufacturers and organized crime groups in the world’s most populous country are responsible for the majority of fentanyl – the synthetic opioid that is 50 times more potent than heroin – that ends up in the U.S. and the majority of precursor chemicals used by Mexican drug cartels to make methamphetamine
The Apple Watch has seen major sales declines in the first part of 2016 -- but the new Series 2 version could take market share from Fitbit.
Deutsche Bank upgrades shares of the media giant, setting a price target of $112. Disney isn't running on all cylinders, but it's doing just enough to make Wall Street believe again.
One of these two is just too darn expensive.
If you’re planning on visiting Pluto anytime soon, best to bring some warm boots. A frigid, possibly “slushy” subsurface ocean could be lurking under the crust of the dwarf planet.
Pay attention investors: The knowledge bombs that CEO Dave Lesar dropped on the company's most recent conference call should be included in your investment thesis for the industry.
Will shareholders vote for or against Tesla's acquisition of SolarCity? Here's what investors should know before the votes are tallied.
The future of U.S. renewables and clean energy-related exchange traded funds looks dim as President-elect Donald Trump takes office and a Republicans control both the House of Representatives and the Senate. The clean energy sector has found support under President Barack Obama as the administration pledged to fight against global warming and climate change through…
A leading hotel REIT could produce income and growth in your portfolio.
Candy stocks like Hershey and Mondelez are facing a tough road ahead: Even with past high performance and dividends, the future could be bleak.
Why Shares of Flexion Therapeutics, Inc., Lantheus Holdings Inc, and PDL BioPharma Inc Are Tanking Today
All three healthcare companies' stocks fell hard after they announced intentions to raise capital.